Lumos Diagnostics surges 140% on major US contract deal
Lumos Diagnostics (ASX:LDX) has surged 140% to 7cps after inking a $420M deal for use of its fingerprick blood test to determine if...
The Watchlist
Previous Video
Next Video
LU7
LITHIUM UNIVERSE LIMITED
Iggy Tan, Executive Chairman
Iggy Tan
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online